

Saad Amer
SAAD AMER, The Derby Medical School, Nottingham University
More reassurance about the use of clomifene for treating anovulatory women with polycystic ovarian syndrome has emerged from a randomised study from Nottingham reported to the fertility conference held in Lyon. Laparoscopic ovarian diathermy, normally used as second line treatment (after clomifene), was found to be equivalent for inducing ovulation and pregnancy in a study with over sixty women. But Saad Amer explained to Sarah Maxwell why he still favours clomifene.